Saturday 17 October 2026
Export CC’s income statement to Excel — free account
The Chemours Company
CC Basic Materials Specialty Chemicals
The Chemours Company’s revenue for fiscal 2025 (year ended December 2025) was $5.8 billion, roughly unchanged from fiscal 2024. In the quarter to June 2026, revenue fell 1.49%, EPS grew 28.7%, free cash flow grew 128.0% and total debt fell 6.47%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
12.66
0.25
−1.94%
Follow CC
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
0.54 | 0.57 | 0.31 | 0.41 | |
P/FCF ratio |
14.23 | 21.57 | 34.73 | 0.00 | |
P/Operating CF |
19.64 | (75.49) | 12.93 | 16.31 | |
P/B ratio |
0.00 | 15.38 | 7.06 | 7.94 | |
Price to Tangible BV |
0.00 | 19.77 | 8.73 | 9.45 | |
EV/Sales |
1.09 | 1.18 | 0.90 | 1.01 | |
EV/EBITDA |
29.05 | 27.47 | 18.26 | 16.44 | |
EV/Operating CF |
15.88 | 20.77 | 19.85 | 22.33 | |
EV/FCF |
28.92 | 44.78 | 102.75 | (739.76) | |
Quick Ratio |
0.85 | 0.82 | 0.80 | 0.83 | |
Current Ratio |
1.66 | 1.82 | 1.78 | 1.71 | |
Net Debt/EBITDA |
(24.44) | 33.09 | 54.20 | 20.10 | |
Debt/Assets |
54.15% | 56.93% | 56.10% | 54.82% | |
Debt/Equity |
(80.67) | 19.15 | 16.50 | 13.83 | |
Asset Turnover |
0.79 | 0.79 | 0.78 | 0.78 | |
Operating CF/Net income |
(0.58) | 1.52 | (2.25) | 2.43 | |
Capex/Depreciation |
(0.54) | (0.60) | (0.63) | (0.41) | |
Interest Coverage |
(3.13) | 0.38 | (0.28) | 1.38 | |
Research and Development Expense of Revenue |
1.70% | 1.88% | 2.03% | 1.74% | |
Selling, General and Administrative Expense of Revenue |
29.48% | 10.64% | 10.75% | 7.29% | |
Intangible Assets out of Total Assets |
0.01 | 0.01 | 0.01 | 0.01 | |
Share Based Compensation of Revenue |
0.44% | 0.51% | 0.30% | 0.33% | |
Graham Net Nets |
(1.32) | (1.24) | (2.33) | (1.71) | |
Graham Number |
3.69 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(9.31%) | (11.98%) | (21.03%) | (14.26%) | |
Free Cash Flow Yield |
7.03% | 4.64% | 2.88% | (0.34%) | |
Revenue per Share |
10.52 | 9.16 | 8.85 | 9.95 | |
Operating CF per Share |
1.04 | (0.29) | 0.91 | 0.97 | |
Capex per Share |
(0.29) | (0.32) | (0.35) | (0.23) | |
Free Cash Flow per Share |
0.75 | (0.62) | 0.57 | 0.75 | |
Cash per Share |
4.44 | 3.73 | 4.47 | 4.08 | |
Shareholders Equity per Share |
(0.32) | 1.43 | 1.67 | 2.00 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(0.32) | 1.43 | 1.67 | 2.00 | |
Free Cash Flow |
114.00 | (93.00) | 85.00 | 112.00 | |
Working Capital |
1,233.00 | 1,319.00 | 1,315.00 | 1,327.00 | |
Capital Expenditures |
(44.00) | (49.00) | (52.00) | (34.00) | |
Net Current Asset Value |
(4,104.00) | (4,123.00) | (4,130.00) | (4,063.00) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 394.54 | |
Capex to Sales |
0.03 | 0.04 | 0.04 | 0.02 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 158.74 | |
| Other line items | |||||
Average Receivables |
933.00 | 808.50 | 724.50 | 949.00 | |
Average Payables |
980.00 | 948.50 | 1,055.00 | 1,052.00 | |
Average Inventory |
1,505.00 | 1,543.00 | 1,516.00 | 1,492.50 | |
Average Assets |
7,319.00 | 7,330.50 | 7,445.50 | 7,516.50 | |
Average Common Equity |
95.50 | 398.00 | 411.50 | 479.50 |
Columns are period end dates